Emilie Roncali

h-index3
2papers

2 Papers

IVAug 30, 2025
Towards Digital Twins for Optimal Radioembolization

Nisanth Kumar Panneerselvam, Guneet Mummaneni, Emilie Roncali

Radioembolization is a localized liver cancer treatment that delivers radioactive microspheres (30 micron) to tumors via a catheter inserted in the hepatic arterial tree. The goal is to maximize therapeutic efficacy while minimizing damage to healthy liver tissue. However, optimization is challenging due to complex hepatic artery anatomy, variable blood flow, and uncertainty in microsphere transport. The creation of dynamic, patient-specific digital twins may provide a transformative solution to these challenges. This work outlines a framework for a liver radioembolization digital twin using high-fidelity computational fluid dynamics (CFD) and/or recent physics-informed machine learning approaches. The CFD approach involves microsphere transport calculations in the hepatic arterial tree with individual patient data, which enables personalized treatment planning. Although accurate, traditional CFD is computationally expensive and limits clinical applicability. To accelerate simulations, physics-informed neural networks (PINNs) and their generative extensions play an increasingly important role. PINNs integrate governing equations, such as the Navier-Stokes equations, directly into the neural network training process, enabling mesh-free, data-efficient approximation of blood flow and microsphere transport. Physics-informed generative adversarial networks (PI-GANs), diffusion models (PI-DMs), and transformer-based architectures further enable uncertainty-aware, temporally resolved predictions with reduced computational cost. These AI surrogates not only maintain physical fidelity but also support rapid sampling of diverse flow scenarios, facilitating real-time decision support. Together, CFD and physics-informed AI methods form the foundation of dynamic, patient-specific digital twin to optimize radioembolization planning and ultimately improve clinical outcomes.

MED-PHJun 3, 2024
Nuclear Medicine AI in Action: The Bethesda Report (AI Summit 2024)

Arman Rahmim, Tyler J. Bradshaw, Guido Davidzon et al.

The 2nd SNMMI Artificial Intelligence (AI) Summit, organized by the SNMMI AI Task Force, took place in Bethesda, MD, on February 29 - March 1, 2024. Bringing together various community members and stakeholders, and following up on a prior successful 2022 AI Summit, the summit theme was: AI in Action. Six key topics included (i) an overview of prior and ongoing efforts by the AI task force, (ii) emerging needs and tools for computational nuclear oncology, (iii) new frontiers in large language and generative models, (iv) defining the value proposition for the use of AI in nuclear medicine, (v) open science including efforts for data and model repositories, and (vi) issues of reimbursement and funding. The primary efforts, findings, challenges, and next steps are summarized in this manuscript.